# Legend Biotech (LEGN) — News

LEGN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/legn/news

## Recent headlines

- [Legend Biotech: FDA clearance of ind application for LB2501](https://www.ainvest.com/news/legend-biotech-fda-clearance-ind-application-lb2501-2610) — AInvest Wire, Oct 15, 2026
- [Legend Biotech Corporation - FDA clears IND application for Legend Biotech's LB2501](https://www.ainvest.com/news/legend-biotech-corporation-fda-clears-ind-application-legend-biotech-lb2501-2610) — AInvest Wire, Oct 15, 2026
- [Legend Biotech announces U.S. FDA clearance of ind application for LB2501, an investigational CD19/CD20 in vivo CAR-T therapy](https://www.ainvest.com/news/legend-biotech-announces-fda-clearance-ind-application-lb2501-investigational-cd19-cd20-vivo-car-therapy-2610) — AInvest Wire, Oct 15, 2026
- [Logitech International - Reduces share capital to CHF 39.04 mln - SEC filing](https://www.ainvest.com/news/logitech-international-reduces-share-capital-chf-39-04-mln-sec-filing-2610) — AInvest Wire, Oct 13, 2026
  Logitech International S.A. has announced a reduction in its share capital to CHF 39.04 million, as disclosed in a recent SEC filing. The move is part of the company’s ongoing corporate governance strategy and reflects adjustments to its capital structure. The filing, submitted under the Securities…
- [Legend Biotech launches inaugural elite grant program to advance the next generation of CAR-T innovation in multiple myeloma](https://www.ainvest.com/news/legend-biotech-launches-inaugural-elite-grant-program-advance-generation-car-innovation-multiple-myeloma-2610) — AInvest Wire, Oct 1, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).